Chandra Bhagat Pharma Limited (CBPL.BO)
BSE · INR · Healthcare · Medical Distribution
₹42.90 (+0.00%) as of
Key statistics
- Market cap
- 323.68M
- P/E (TTM)
- 11.69
- EPS (TTM)
- 3.67
- Dividend yield
- 0.00%
- 52-week range
- 29.70 – 52.99
- Beta
- 0.38
- Revenue (TTM)
- 1.17B
- Profit margin
- 2.61%
- Volume
- 2.00k
About Chandra Bhagat Pharma Limited
Chandra Bhagat Pharma Limited, a pharmaceutical company, markets pharmaceutical critical care and health care products in India and internationally. The company offers pharmaceutical formulations, including intravenous and intramuscular injections, oral solids, tablets, capsules, liquid orals, syrup suspensions, injectable liquids, powders, lyophilized ampoules, vials, prefilled syringes, and small and large volume parenteral for various therapeutic categories, such as anti-cancer, anti-infective, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to hospitals and health care centers through its own distribution networks and sales force under its own brand. It also promotes and markets specialty chemicals, intermediates, and active pharmaceuticals ingredients. In addition, the company manufactures pharmaceuticals. It exports its products. Chandra Bhagat Pharma Limited was founded in 1944 and is based in Mumbai, India.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Mumbai, India
- Employees
- 45
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.